Recombinant multi-species SMAD2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SMAD2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]
The Alternative Names of target: 7120426M23Rik,CHTD8,JV18,JV18-1,LDS6,MAD homolog 2,MADH2,MADR2,Mad-related protein 2 (hMAD-2),Madh2,Madr2,Mothers against DPP homolog 2,Mothers against decapentaplegic homolog 2,SMAD family member 2 (SMAD 2,SMAD2,Smad-2,Smad2,hMAD-2,hSMAD2,hSMAD2),mMad2
Go
to SMAD2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP1753-Ag-1/ GM-Tg-hg-IP1753-Ag-2 | Human SMAD2 protein | Human |
| GM-Tg-rg-IP1753-Ag-1/ GM-Tg-rg-IP1753-Ag-2 | Rat SMAD2 protein | Rat |
| GM-Tg-mg-IP1753-Ag-1/ GM-Tg-mg-IP1753-Ag-2 | Mouse SMAD2 protein | Mouse |
| GM-Tg-cynog-IP1753-Ag-1/ GM-Tg-cynog-IP1753-Ag-2 | Cynomolgus/Rhesus macaque SMAD2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP1753-Ag-1/ GM-Tg-felg-IP1753-Ag-2 | Feline SMAD2 protein | Feline |
| GM-Tg-cang-IP1753-Ag-1/ GM-Tg-cang-IP1753-Ag-2 | Canine SMAD2 protein | Canine |
| GM-Tg-bovg-IP1753-Ag-1/ GM-Tg-bovg-IP1753-Ag-2 | Bovine SMAD2 protein | Bovine |
| GM-Tg-equg-IP1753-Ag-1/ GM-Tg-equg-IP1753-Ag-2 | Equine SMAD2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP1753-Ag-1/ GM-Tg-hg-IP1753-Ag-2;
GM-Tg-rg-IP1753-Ag-1/ GM-Tg-rg-IP1753-Ag-2;
GM-Tg-mg-IP1753-Ag-1/ GM-Tg-mg-IP1753-Ag-2; GM-Tg-cynog-IP1753-Ag-1/ GM-Tg-cynog-IP1753-Ag-2; GM-Tg-felg-IP1753-Ag-1/ GM-Tg-felg-IP1753-Ag-2; GM-Tg-cang-IP1753-Ag-1/ GM-Tg-cang-IP1753-Ag-2; GM-Tg-bovg-IP1753-Ag-1/ GM-Tg-bovg-IP1753-Ag-2; GM-Tg-equg-IP1753-Ag-1/ GM-Tg-equg-IP1753-Ag-2 |
| Products Name | SMAD2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SMAD2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SMAD2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.